Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Tango Therapeutics (TNGX) Shares Outstanding (Weighted Average): 2020-2025

Historic Shares Outstanding (Weighted Average) for Tango Therapeutics (TNGX) over the last 6 years, with Sep 2025 value amounting to $111.3 million.

  • Tango Therapeutics' Shares Outstanding (Weighted Average) rose 3.84% to $111.3 million in Q3 2025 from the same period last year, while for Jun 2025 it was $108.4 million, marking a year-over-year increase of 1.45%. This contributed to the annual value of $107.4 million for FY2024, which is 5.32% up from last year.
  • Latest data reveals that Tango Therapeutics reported Shares Outstanding (Weighted Average) of $111.3 million as of Q3 2025, which was up 2.64% from $108.4 million recorded in Q2 2025.
  • Over the past 5 years, Tango Therapeutics' Shares Outstanding (Weighted Average) peaked at $111.3 million during Q3 2025, and registered a low of $21.4 million during Q1 2021.
  • In the last 3 years, Tango Therapeutics' Shares Outstanding (Weighted Average) had a median value of $106.8 million in 2024 and averaged $102.1 million.
  • Data for Tango Therapeutics' Shares Outstanding (Weighted Average) shows a peak YoY soared of 444.16% (in 2021) over the last 5 years.
  • Quarterly analysis of 5 years shows Tango Therapeutics' Shares Outstanding (Weighted Average) stood at $87.5 million in 2021, then rose by 0.72% to $88.2 million in 2022, then rose by 15.66% to $102.0 million in 2023, then climbed by 5.32% to $107.4 million in 2024, then climbed by 3.84% to $111.3 million in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $111.3 million for Q3 2025, versus $108.4 million for Q2 2025 and $108.1 million for Q1 2025.